CD44 and breast neoplasm: In line with other studies [56, 75], the CD44+/CD24low/− sub-population comprised only ~1% of the original Luminal-A breast tumor cells, but we demonstrated that the proportion of these cells was profoundly increased by TME Stimulation (to ~15% or ~5%, in MCF-7 and T47D cells, respectively).